Optimizing PCI 2020 - Session II: Cracking the Calcium Conundrum

Works at Montefiore Medical Center, New York, NY, US. Features in 40 videos on Wondr Medical. Azeem Latib generally speaks on Bioresorbable Vascular Scaffold (BVS), Drug Eluting Stents (DES), Intravascular Ultrasound (IVUS), Bifurcation, and Intracoronary Imaging.

Dr. Pinto received his B.A., cum Laude, from Dartmouth College in Hanover, NH and M.D. degree from the Georgetown University, cum Laude and Alpha Omega Alpha. He was an Intern, Resident, Chief Resident, General Cardiology Fellow and Interventional Cardiology Fellow at Harvard Medical School and Beth Israel Hospital, Boston, MA. Dr. Pinto is an Associate Professor of Medicine at Harvard Medical School and serves as the Director of the Cardiac Intensive Care Unit, Associate Chief of the Interventional Section and Director of the General Cardiology Fellowship Program at Beth Israel Deaconess Medical Center. He has been awarded cardiology fellow teaching and mentorship awards from Harvard Medical School. His clinical expertise is in general and interventional cardiology. In addition to a busy outpatient practice, he performs coronary and peripheral angioplasty and stenting procedures. These include stenting and other procedures in the heart, leg, abdominal and neck arteries. Dr. Pinto has research interests in a wide variety of topics including acute myocardial infarction studies, unstable angina studies, interventional trials, peripheral interventional trials specializing in clinical outcome, comparative effectiveness and cost-effectiveness studies. Dr. Pinto is the editor of the Controversies in Cardiology section for Circulation. He is a manuscript reviewer for the New England Journal, Circulation and the Journal of the American College of Cardiology. He has published over 75 articles in journals such as The New England Journal of Medicine, Circulation, Journal of the American College of Cardiology and JAMA. His work highlights the management and outcomes of patients with cardiac and vascular disorders.

An internationally recognized interventional cardiologist, Dr. Moses has performed more than 15,000 interventional procedures, authored over 600 publications, and served as lead investigator for numerous national and international clinical studies that have demonstrated the effectiveness and safety of coronary stent placement. In 2002, Dr. Moses was the lead investigator on a large clinical trial, the first in the U.S. that demonstrated the enormous benefit that led to FDA approval of the first drug-coated stent now used in the majority of interventional procedures in the U.S. Most recently in on the Executive Committee of PARTNER trial; they brought the first transcatheter aortic valve to clinical use in the U.S. He currently serves as Director of Interventional Cardiovascular Therapeutics at Columbia University Medical Center and as Director of Advanced Cardiac Interventions at St Francis Hospital and Heart Center in Roslyn, NY. He is also a pioneer in developing approaches involving minimally invasive surgery, angioplasty, gene therapy, novel imaging technologies and various support devices that allow for wider application of interventional cardiovascular procedures.

Dr. Kevin J. Croce is an interventional cardiologist and the director of the Chronic Total Occlusion Complex Percutaneous Coronary Intervention Program at Brigham and Women’s Hospital (BWH). He is an assistant professor of medicine at Harvard Medical School (HMS) who also directs the BWH Translational Discovery Laboratory which is a centralized research facility that uses state-of-the-art technology to perform preclinical testing of promising therapies and medical devices. Dr. Croce received his medical and Ph.D. degrees from Tufts University School of Medicine. He completed an internal medicine residency, a cardiology fellowship and an interventional cardiology fellowship at BWH. Dr. Croce is board certified in internal medicine, cardiovascular disease and interventional cardiology. His clinical interests include advanced treatments for obstructive coronary artery disease (CAD), and optimization of antithrombotic and antiplatelet pharmacotherapy. The author of over 50 peer-reviewed publications, Dr. Croce’s research focuses on understanding the molecular pathobiology of atherothrombotic (CAD) and on identifying new targets for CAD treatment. His research has received support from the National Institutes of Health.

Newell Robinson, MD, is Chairman of Cardiothoracic and Vascular Surgery at St. Francis Hospital, as well as Co-director of the Heart Valve Center at St. Francis Hospital. He is a board certified cardiothoracic surgeon who has been recognized nationally for his expertise in minimally-invasive cardiac surgery. As Co-Principal Inves­tigator of the CoreValve clinical study, his published findings, helped gain FDA approval of the device. Dr. Robinson has also been pivotal in bringing state-of-the-art technology to St. Francis Hospital, including a hybrid OR that allows interven­tional cardiologists and cardiothoracic surgeons to work side by side for the benefit of patients. Dr. Robinson is consistently cited on New York magazine’ Best Doctors list, in addition to being rated among the top physicians in the country by Castle Connolly.